All News

Found 90 articles

• Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites

  12/16/2020

  Exo Therapeutics , Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion of a $25 million Series A financing. Investors in the round included Newpath Partners, Novartis Ventur

• Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress

  11/19/2020

  Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage company focused on pioneering the development of exosome-based therapeutics, today reported third quarter 2020 financial results and operational progress.

• 

  BioSpace Global Roundup, Nov. 12

  11/12/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• Silicon Valley Startup Exo Secures $40M in Series B+ Funding to Advance Handheld Medical Imaging

  8/24/2020

  Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product development on a revolutionary handheld medical device and cloud-based workflow software platform.

• ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

  7/7/2020

  ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).

• 

  BioSpace Movers & Shakers, May 22

  5/22/2020

  Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.

• Top Ultrasound Industry Talent Joining Exo Imaging

  11/5/2019

  Medical Imaging Startup makes key additions to commercialization and product teams

• Flagship Pioneering Unveils Cygnal Therapeutics

  10/8/2019

  Company is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More   [08-October-2019]   CAMBRIDGE, Mass. , Oct. 8, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics . Founded in 2017 in Flagship Labs, Flagship's innovation foundry, Cygnal is the first co

• Tyto Care Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

  10/2/2019

  CB Insights today named Tyto Care to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world.

• LetsGetChecked Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

  10/2/2019

  LetsGetChecked recognized for achievements in home health testing

• Deep Lens, Inc. Named to the 2019 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups

  10/2/2019

  Deep Lens, Inc. recognized for achievements in Best Application of AI

• OSF Ventures Joins $35M Funding Round for Handheld Ultrasound Device

  8/12/2019

  OSF Ventures has joined a $35 million funding round to support a start-up that's developing a breakthrough handheld, AI ultrasound device that will allow health care providers to make critical, real-time diagnostic decisions.

• Exo Imaging Emerges from Stealth Mode with $35M Series B Financing Round to Advance Development of the Exo Ultrasound Platform

  8/5/2019

  Exo Imaging, Inc., a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications, announced a $35M Series B financing round.

• ExoFest 2019 to Feature Latest Exosome and Extracellular Vesicle Research

  6/5/2019

  Annual One-Day Event Hosted by System Biosciences and UCSF Features Experts in the Field

• NeurExo Sciences and Henry Ford Health System Present Preclinical Data on Exosomes at ISEV2019 Annual Meeting

  4/26/2019

  Exosomes demonstrate ability to enhance anti-tumor effect of platinum-based drugs and to ameliorate peripheral neuropathy

• NewYork-Presbyterian and Columbia University Irving Medical Center Open New Sports Medicine and Performance Training Facility in Westchester

  4/9/2019

  NewYork-Presbyterian, in collaboration with physicians from Columbia University Irving Medical Center, has launched a state-of-the-art sports medicine and performance training facility in Westchester County that gives patients and athletes access to some of the nation's top sports medicine doctors, therapists, and elite sports performance coaches–all at a single location.

• Solera Health Appoints Dr. Andrey Ostrovsky as Chief Medical Officer and Vice President of Behavioral Health

  1/7/2019

  Former Chief Medical Officer of the U.S. Medicaid Program to Expand Platform to Address Behavioral Health and Substance Use Disorders

• Stem Cell Medicine Licenses Exosome Technology for Treating Autism From Ramot at Tel Aviv University

  1/2/2019

  Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple Sclerosis

• DJO Announces New Global Headquarters in Dallas, Texas to Accommodate Growth and Accelerate Innovation

  12/12/2018

  New Dallas focus will bring hundreds of new jobs to the area

• DJO Global Announces Financial Results for Third Quarter 2018

  11/13/2018

  Revenue and Profitability Growth Continue on Strength of Business Transformation